Stress and Resilience (BARS)

July 10, 2025 updated by: Priscilla Lui, University of Washington

Black Adult Resilience Study

Alcohol and cannabis are the most misused psychoactive substances in the United States. The proposed research examines how personally relevant stressful experiences may lead to alcohol and cannabis use. The proposed research is also designed to identify possible targets for prevention and treatment efforts to help reduce drug use.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

456

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: P. Priscilla Lui, Ph.D.
  • Phone Number: 206-685-8391
  • Email: pplui@uw.edu

Study Locations

    • Texas
      • Dallas, Texas, United States, 75204
        • Recruiting
        • Southern Methodist University
        • Contact:
    • Washington
      • Seattle, Washington, United States, 98195
        • Recruiting
        • University of Washington
        • Contact:
          • P. Priscilla Lui, Ph.D.
          • Phone Number: 206-685-8391
          • Email: pplui@uw.edu
        • Sub-Investigator:
          • Kevin M King, Ph.D.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Of Afro-descent
  • Proficient in English
  • Alcohol and/or cannabis use at least 2-3 times in the past month
  • Endorse having used alcohol and/or cannabis to cope

Exclusion Criteria:

  • Having participated in similar studies by the research team
  • Obtain cut-off scores on scale items indicating possible loss of control and needing to cut down or quit alcohol and/or cannabis use
  • In or seeking treatment for alcohol and/or cannabis use disorder

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Direct Interpersonal Exchange
Simulated a negative personally relevant interpersonal experience that is received directly from a perpetrator, commonly experienced in everyday lives
Simulated a negative personally relevant interpersonal experience that is received directly from a perpetrator, commonly experienced in everyday lives
Experimental: Vicarious Interpersonal Exchange
Hearing or observing a negative personally relevant interpersonal experience that is reported by another person of the same background
Hearing or observing a negative personally relevant interpersonal experience that is reported by another person of the same background
Placebo Comparator: Daily Hassles
Day-to-day stressors associated with school, work, finances
Day-to-day stressors associated with school, work, finances

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Duration of Alcohol and Cannabis Intoxication
Time Frame: 48 Hours Post-Intervention
Self-reported number of hours of intoxication within 48 hours after the intervention
48 Hours Post-Intervention
Momentary Alcohol and/or Cannabis Craving
Time Frame: Immediately after the intervention (i.e., within 1 minute)
Momentary Alcohol and Cannabis Craving Scale will be administered (adapted from the Momentary Cannabis Craving Scale; Davis et al., 2024) immediately after the intervention. Mean scores will range from 1 to 7, with higher scores indicating greater momentary craving.
Immediately after the intervention (i.e., within 1 minute)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: P. Priscilla Lui, Ph.D., University of Washington

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 9, 2024

Primary Completion (Estimated)

July 1, 2027

Study Completion (Estimated)

July 1, 2027

Study Registration Dates

First Submitted

May 28, 2024

First Submitted That Met QC Criteria

June 7, 2024

First Posted (Actual)

June 13, 2024

Study Record Updates

Last Update Posted (Actual)

July 15, 2025

Last Update Submitted That Met QC Criteria

July 10, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • STUDY00018058
  • R01DA058626 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alcohol Use

Clinical Trials on Daily Hassles

Subscribe